| MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway. | |
| Zhang Nan; Wei Zhu-Liang; Yin Jing; Zhang Lu; Wang Jin; Jin Zuo-Lin | |
| 刊名 | American journal of translational research
 |
| 2018 | |
| 卷号 | 10页码:3542-3554 |
| 关键词 | miR-106a* apoptosis methyl-CpG binding protein 2 (MeCP2) proliferation Oral squamous cell carcinoma (OSCC) |
| ISSN号 | 1943-8141 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2906815 |
| 专题 | 西安交通大学 |
| 推荐引用方式 GB/T 7714 | Zhang Nan,Wei Zhu-Liang,Yin Jing,et al. MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway.[J]. American journal of translational research,2018,10:3542-3554. |
| APA | Zhang Nan,Wei Zhu-Liang,Yin Jing,Zhang Lu,Wang Jin,&Jin Zuo-Lin.(2018).MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway..American journal of translational research,10,3542-3554. |
| MLA | Zhang Nan,et al."MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway.".American journal of translational research 10(2018):3542-3554. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论